Phibro Animal Health Corporation
PAHC
$38.25
-$0.33-0.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.77% | 10.27% | 20.90% | 39.73% | 38.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.77% | 10.27% | 20.90% | 39.73% | 38.63% |
| Cost of Revenue | 1.69% | 8.46% | 16.84% | 37.33% | 43.19% |
| Gross Profit | 12.06% | 14.17% | 28.98% | 44.80% | 28.91% |
| SG&A Expenses | 14.36% | 14.00% | 17.02% | 16.17% | 17.50% |
| Depreciation & Amortization | 1.22% | -- | -- | -- | -20.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.34% | 9.69% | 16.89% | 31.84% | 36.20% |
| Operating Income | 8.53% | 14.45% | 50.99% | 127.49% | 64.29% |
| Income Before Tax | 35.62% | 8.84% | 652.89% | 277.00% | 272.14% |
| Income Tax Expenses | 60.52% | -5.89% | 442.41% | 268.24% | 17.10% |
| Earnings from Continuing Operations | 26.05% | 15.06% | 762.14% | 280.32% | 2,190.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.05% | 15.06% | 762.14% | 280.32% | 2,190.43% |
| EBIT | 8.53% | 14.45% | 50.99% | 127.49% | 64.29% |
| EBITDA | 8.32% | 10.81% | 41.44% | 102.38% | 58.67% |
| EPS Basic | 25.72% | 14.96% | 761.83% | 280.02% | 2,186.56% |
| Normalized Basic EPS | -9.28% | -6.42% | 161.06% | 120.35% | 148.67% |
| EPS Diluted | 24.59% | 15.69% | 752.42% | 282.35% | 2,186.56% |
| Normalized Diluted EPS | -9.71% | -7.10% | 159.78% | 118.90% | 148.14% |
| Average Basic Shares Outstanding | 0.25% | 0.08% | 0.07% | 0.07% | 0.00% |
| Average Diluted Shares Outstanding | 0.74% | 0.81% | 0.59% | 0.73% | 0.25% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.21% | -0.13% | -0.88% | -0.74% | -0.96% |